SEC Form 4
Insmed, Inc. (INSM) insider trading
In the 12 months to Oct 26, 2026, 9 INSM insiders reported open-market sales of $155.3M across 43 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $155.3M
- 43 filings · 9 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 35 of 43
- $92.0M of $155.3M sold (59%)
Who traded INSM, and when
- Sale
- Sale, pre-arranged (10b5-1)
INSM daily close from Oct 27, 2025 to Oct 26, 2026, between $91.88 and $211.41, last $93.23. 43 sale and 0 purchase filings by 9 insiders, marked at their filing dates. Roger Adsett, Chief Operating Officer: sold $46.5M across 2 filings, first filed Apr 3, 2026, last Aug 12, 2026. William Lewis, Chair and CEO: sold $28.3M across 16 filings, first filed Dec 5, 2025, last Jul 24, 2026. Martina M.D. Flammer, Chief Medical Officer: sold $21.2M across 12 filings, first filed Nov 13, 2025, last Aug 7, 2026. Orlov S. Nicole Schaeffer, Chief People Strategy Officer: sold $21.1M across 2 filings, first filed Nov 14, 2025, last Jan 6, 2026. Leo Lee, Director: sold $14.7M across 1 filing, first filed Nov 18, 2025, last Nov 18, 2025. Michael Alexander Smith, Chief Legal Officer: sold $12.7M across 5 filings, first filed Nov 5, 2025, last Jun 24, 2026. 3 others: sold $10.8M across 5 filings, first filed Nov 18, 2025, last Sep 11, 2026.
Largest mark · tap a row for others
Roger Adsett · Chief Operating Officer
Sale $31,964,810
239,850 shares at $133.27 avg
Filed Aug 12, 2026 · traded Aug 10
Close on filing date $132.28
Roger Adsett · Chief Operating Officer
Chief Operating Officer
$46.5M soldWilliam Lewis · Chair and CEO
Chair and CEO
$28.3M soldMartina M.D. Flammer · Chief Medical Officer
Chief Medical Officer
$21.2M soldOrlov S. Nicole Schaeffer · Chief People Strategy Officer
Chief People Strategy Officer
$21.1M soldLeo Lee · Director
Director
$14.7M soldMichael Alexander Smith · Chief Legal Officer
Chief Legal Officer
$12.7M sold3 others
Combined, one mark per week
$10.8M soldOpen-market trades
43 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Roger Adsett | Chief Operating Officer | $46.5M | — | 2 | 31% of sales | |
| William Lewis | Chair and CEO | $28.3M | — | 16 | 100% of sales | |
| Martina M.D. Flammer | Chief Medical Officer | $21.2M | — | 12 | 100% of sales | |
| Orlov S. Nicole Schaeffer | Chief People Strategy Officer | $21.1M | — | 2 | 72% of sales | |
| Leo Lee | Director | $14.7M | — | 1 | — | |
| Michael Alexander Smith | Chief Legal Officer | $12.7M | — | 5 | 100% of sales | |
| Melvin Md Sharoky | Director | $4.7M | — | 2 | — | |
| David R. Brennan | Director | $3.1M | — | 1 | — | |
| Elizabeth M. Anderson | Director | $3.0M | — | 2 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | David R. Brennan Director | Sale | 25,000 | $124.00 | $3.1M | 39,238 | |
traded | Melvin Md Sharoky Director | Sale | 5,000 | $127.53 | $637.7K | 0 | |
traded | Roger Adsett Chief Operating Officer | Sale | 239,850 | $133.27 | $32.0M | 98,744 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 27,173 | $128.61 | $3.5M | 60,486 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 10,700 | $106.06 | $1.1M | 264,930 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 10,699 | $117.40 | $1.3M | 262,417 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 12,302 | $109.98 | $1.4M | 60,486 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 21,398 | $103.32 | $2.2M | 262,665 | |
traded | Michael Alexander Smith Chief Legal Officer | SalePre-arranged (10b5-1) | 1,806 | $95.82 | $173.1K | 37,648 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 6,515 | $94.03 | $612.6K | 258,917 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 1,858 | $103.78 | $192.8K | 60,486 | |
traded | Michael Alexander Smith Chief Legal Officer | SalePre-arranged (10b5-1) | 6,149 | $108.47 | $667.0K | 41,613 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 25,564 | $106.33 | $2.7M | 273,037 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 10,479 | $117.54 | $1.2M | 64,910 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 12,949 | $100.40 | $1.3M | 83,243 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 10,699 | $137.34 | $1.5M | 302,813 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 10,699 | $143.97 | $1.5M | 309,638 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 10,699 | $163.22 | $1.7M | 301,185 | |
traded | Roger Adsett Chief Operating Officer | SalePre-arranged (10b5-1) | 88,060 | $164.63 | $14.5M | 169,154 | |
traded | Michael Alexander Smith Chief Legal Officer | SalePre-arranged (10b5-1) | 19,638 | $150.98 | $3.0M | 51,871 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 10,699 | $143.52 | $1.5M | 305,718 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 10,699 | $146.03 | $1.6M | 303,313 | |
traded | Michael Alexander Smith Chief Legal Officer | SalePre-arranged (10b5-1) | 24,774 | $155.77 | $3.9M | 67,642 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 10,699 | $150.97 | $1.6M | 304,592 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 13,396 | $147.79 | $2.0M | 301,185 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 869 | $152.44 | $132.5K | 83,243 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 7,982 | $154.59 | $1.2M | 91,398 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 10,699 | $158.93 | $1.7M | 316,584 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 19,215 | $169.00 | $3.2M | 307,960 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 1,887 | $186.19 | $351.3K | 84,907 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 11,821 | $173.96 | $2.1M | 86,794 | |
traded | Orlov S. Nicole Schaeffer Chief People Strategy Officer | SalePre-arranged (10b5-1) | 87,290 | $175.20 | $15.3M | 41,754 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 12,303 | $171.38 | $2.1M | 101,053 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 10,699 | $166.97 | $1.8M | 311,651 | |
traded | Melvin Md Sharoky Director | Sale | 20,000 | $205.01 | $4.1M | 243,948 | |
traded | William Lewis Chair and CEO | SalePre-arranged (10b5-1) | 10,699 | $205.62 | $2.2M | 310,094 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 8,895 | $206.98 | $1.8M | 84,670 | |
traded | Elizabeth M. Anderson Director | Sale | 5,000 | $204.58 | $1.0M | 58,729 | |
traded | Leo Lee Director | Sale | 75,000 | $195.90 | $14.7M | 126,465 | |
traded | Elizabeth M. Anderson Director | Sale | 10,000 | $195.87 | $2.0M | 63,729 | |
traded | Orlov S. Nicole Schaeffer Chief People Strategy Officer | Sale | 30,000 | $194.00 | $5.8M | 62,383 | |
traded | Martina M.D. Flammer Chief Medical Officer | SalePre-arranged (10b5-1) | 31,226 | $189.68 | $5.9M | 83,111 | |
traded | Michael Alexander Smith Chief Legal Officer | SalePre-arranged (10b5-1) | 27,130 | $183.78 | $5.0M | 64,753 |
GET /stocks/filings/vX/form-4?tickers=INSM&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"INSM"
],
"issuer_cik": "0001104506",
"owner_cik": "0001609305",
"accession_number": "0001609305-26-000009",
"form_type": "4",
"filing_date": "2026-09-11",
"period_of_report": "2026-09-09",
"issuer_name": "INSMED Inc",
"issuer_trading_symbol": "INSM",
"owner_name": "Brennan David R",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-09",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 25000,
"transaction_price_per_share": 124,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 39238,
"transaction_value": 3100000,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"INSM"
],
"issuer_cik": "0001104506",
"owner_cik": "0001182633",
"accession_number": "0001182633-26-000010",
"form_type": "4",
"filing_date": "2026-08-19",
"period_of_report": "2026-08-17",
"issuer_name": "INSMED Inc",
"issuer_trading_symbol": "INSM",
"owner_name": "SHAROKY MELVIN MD",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-17",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 5000,
"transaction_price_per_share": 127.53,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 0,
"transaction_value": 637650,
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "By Padonia, LLC",
"footnotes": [
{
"id": "F1",
"description": "This is the weighted average sales price representing 5,000 shares sold at prices ranging from $127.51 to $127.61 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request."
},
{
"id": "F2",
"description": "The Reporting Person is the managing member of Padonia, LLC."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 111 records
- Option exercises52 records
- Tax withholding (sold to cover)31 records
- Grants and awards17 records
- Gifts11 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Insmed, Inc.'s CEO sold stock?
Yes. William Lewis (CEO) sold 203,778 shares ($28.3M) between Dec 2025 and Jul 2026, all under a pre-arranged 10b5-1 plan.
How current is INSM’s insider data?
These are INSM Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track INSM insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for INSM every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.